Abstract: Poster Presentations |

Comparison of the Efficacy of Inhaled Ipratropium Bromide and Salbutamol Sequentially and in Fixed Dose Combination in Patients With Stable Bronchial Asthma FREE TO VIEW

Anant Mohan, Senior Research Associate; Randeep Guleria, Additional Professor; Chinmoyee Das, Research Fellow; Rajesh Sharma, Research Associate
Author and Funding Information

All India Institute of Medical Sciences, New Delhi, India


Chest. 2003;124(4_MeetingAbstracts):139S. doi:10.1378/chest.124.4_MeetingAbstracts.139S-a
Text Size: A A A
Published online


PURPOSE:  Inhaled anticholinergics and Beta- 2 agonists are frequently combined to achieve optimal bronchodilatation in bronchial asthma. Fixed dose combinations of these agents are being widely used. However, it is unclear whether sequential administration of these drugs is better than simultaneous administration. This study was done to compare the bronchodilatation produced by a fixed dose combination with that produced by the same drugs administered sequentially.

METHODS:  27 consecutive patients with stable bronchial asthma were randomly selected for two spirometry sessions held within a week. In one session, they were given inhaled Ipratropium Bromide (40 μg) followed 30 minutes later by Salbutamol (200 μg ).In the other session, the same drugs in similar dosage were administered through a fixed dose combination. Spirometry was performed at baseline and at 15,30 and 60 minutes post inhalation. The change in Forced Vital Capacity (FVC), Forced Expiration in one second (FEV1), Peak Expiratory Flow Rate (PEFR) and Forced Expiratory Flow (FEF 25–75 ) was measured and compared.

RESULTS:  The mean age was 30.5 years. There was no significant difference between the baseline values of FVC, FEV1, PEFR and FEF 25–75 in the two groups. FEV1 increased significantly by a mean of 234.4 ± 40, 329.6 ± 44, and 335.9 ± 45 ml respectively at 15,30 and 60 minutes from baseline in the fixed combination group, and by 202.6 ± 32, 244.8 ± 27 and 204.8 ± 31 ml in the sequential group. A similar trend was noted for the other parameters. However, there was no significant difference in any of these parameters at 15,30 or 60 minutes between the two groups.

CONCLUSION:  Inhalation of a fixed dose combination of an anticholinergic agent and a beta-2 agonist is equally effective in producing bronchodilatation as administering the same drugs in sequential order.

CLINICAL IMPLICATIONS:  Fixed dose combination inhalers are equally effective and have a better compliance compared to the use of these drugs separately in a sequential manner.

DISCLOSURE:  A. Mohan, None.

Wednesday, October 29, 2003

12:30 PM - 2:00 PM




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
Management of status asthmaticus in children. Recent Pat Inflamm Allergy Drug Discov Published online 01 30, 2017;
Asthma in pregnancy.
American College of Obstetricians and Gynecologists | 9/19/2008
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543